Prospective Study
Copyright ©The Author(s) 2025.
World J Diabetes. Jan 15, 2025; 16(1): 98322
Published online Jan 15, 2025. doi: 10.4239/wjd.v16.i1.98322
Figure 1
Figure 1 Graphic abstract of the results. T2DM: Type 2 diabetes; HbA1c: Glycated hemoglobin.
Figure 2
Figure 2 Baseline and 12th month medication usage: Group A vs group B. DPP-IV: Dipeptidyl peptidase IV; SGLT2: Sodium-glucose transport protein 2; SU/GLN: Sulfonylurea/glinides.
Figure 3
Figure 3 The success rates of the groups in attaining glycemic control. HbA1c: Glycated hemoglobin.